We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Smoking status: not checked. AREDS2 Formula: what these mean for you changes depending on whether you smoke or used to, and you have not told us. That check was skipped.
Head-to-head evidence comparison — which supplement is right for you?
AREDS2 Formula vs Zinc: Zinc has the stronger overall evidence (8.5 vs 7/10); they work on different things and are often used together, not either/or. Take the 60-second quiz for a pick tailored to your goals.
Zinc wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
One AREDS2 daily regimen, usually split into two servings: vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc 80 mg (as zinc oxide) and copper 2 mg (as cupric oxide)
with-meals
A product matching the AREDS2 composition exactly: vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc 80 mg, copper 2 mg
15-25mg daily
With meals
Zinc picolinate or zinc citrate
and 3 more not shown
and 4 more not shown
The formula already supplies 80 mg of zinc, more than three times the 25 mg EFSA tolerable upper intake and double the 40 mg FDA figure. Stacking another zinc product pushes intake into the range where zinc-induced copper deficiency, anaemia and neutropenia are documented. Do not add zinc on top.
Discuss with your healthcare provider before combining.
Years — average follow-up was 6.3 years
Years
Long-term
Years
2-4 weeks
2-4 weeks
4-8 weeks
Immediate
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
JAMA (2013) · Rct · n=4203
Primary analysis was NULL: lutein/zeaxanthin HR 0.90 (98.7% CI 0.76-1.07, P=.12); DHA+EPA HR 0.97 (0.82-1.16, P=.70); both together HR 0.89 (0.75-1.06, P=.10)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Arch Ophthalmol (2001) · Rct · n=3640
Antioxidants plus zinc vs placebo for advanced AMD: OR 0.72 (99% CI 0.52-0.98). Zinc alone OR 0.75 (0.55-1.03); antioxidants alone OR 0.80 (0.59-1.09) — neither significant on its own
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
JAMA Ophthalmol (2022) · Cohort · n=3882
10-year lung cancer odds ratio: 1.82 (95% CI 1.06-3.12, P=.02) for beta-carotene assignment vs 1.15 (0.79-1.66, P=.46) for lutein/zeaxanthin
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta analysis · n=739
Zinc supplementation significantly reduced pain severity compared to placebo (Hedges's g = -1.541; 95% CI: -2.268 to -0.814; p < 0.001), representing a clinically meaningful reduction in pain.
Effects of Daily Zinc Alone or in Combination with Other Nutrient Supplements on the Risk of Malaria Parasitaemia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Nutrients (2023) · Meta analysis · n=1339
The effect sizes, represented as risk ratios (RRs) with 95% confidence intervals (CIs), were standardised by transforming them into log RRs and then pooling them using a fixed-effects or random-effects model depending on the heterogeneity across studies.
Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Nutrients (2022) · Meta analysis · n=806
Pooled analyses by the IBD subgroup showed a total population of 1677 with CD, for an overall mean zinc deficiency prevalence of 54% and 95% confidence intervals (CI) ranging from 0.51 to 0.56, versus 41% (95%CI 0.38-0.45) in the UC population (n = 806).
Based on meta-analyses showing reduced respiratory tract infections and improved immune markers (CD3/CD4). Effects primarily in deficient individuals. Take with food to reduce nausea risk.
AI-estimated from published studies. Interpret as directional guidance.
Zinc has a higher evidence score (8.5/10 vs 7/10) and wins in 3 of 3 categories.
The formula already supplies 80 mg of zinc, more than three times the 25 mg EFSA tolerable upper intake and double the 40 mg FDA figure. Stacking another zinc product pushes intake into the range where zinc-induced copper deficiency, anaemia and neutropenia are documented. Do not add zinc on top. Discuss with your healthcare provider before combining. Consult a healthcare provider for personalized advice.
AREDS2 works for diagnosed AMD; lutein/screen-strain claims are weaker. Who actually benefits.
The popular one (saw palmetto) mostly fails in rigorous trials; beta-sitosterol is the better bet.
Selenium helps; iodine can WORSEN Hashimoto’s. The honest take on "thyroid support".
CoQ10, zinc, selenium, carnitine modestly help sperm parameters — but live-birth evidence is weak.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.